Tumor Inflammatory Signaling (TIS) is an 18-gene signature that indicates genes for sustained adaptive Th1 and cytotoxic CD8+ T cell responses and has shown promising results in predicting response to anti-PD-1/PD-L1 drugs26. Here, CD8A is linked to neoplasm.